Agent orange exposure

Agent orange exposure has been studied in 2 papers since 2026: 2 observational studies in people; 2 in the past year. The newest paper, May 1, 2026: “A31-03 Association of Agent Orange Exposure and Lung Cancer Screening in a National Cohort of Veterans”.

2 papers study it2 findingsUpdated May 1, 2026

At a glance

The findings reach people, from one lab or study. 2 independent labs in 1 country.

“In the fully adjusted model, Agent Orange exposure was associated with higher screening odds (adjusted Odds Ratio (OR)=1.11, 95% CI: 1.08-1.15”

None of its findings points the other way.

Studies of agent orange exposure measured one outcome, lung cancer screening uptake.

Lung cancer screening uptake

upin humans1OR 1.11

1 study

Agent orange exposure is linked with higher lung cancer screening uptake in humans (LCS-eligible VA primary care patients) (adjusted OR 1.11, 95% CI 1.08-1.15).
“In the fully adjusted model, Agent Orange exposure was associated with higher screening odds (adjusted Odds Ratio (OR)=1.11, 95% CI: 1.08-1.15”
HumansLCS-eligible VA primary care patients93% malesn = 171,686
A31-03 Association of Agent Orange Exposure and Lung Cancer Screening in a National Cohort of Veterans
American Journal of Respiratory and Critical Care MedicineMay 1, 2026

Studies link agent orange exposure with acral melanoma.

Acral melanoma

upin humans1

1 study

Agent orange exposure is associated with acral melanoma in humans (US veterans; compared with nonacral cutaneous melanoma controls) (AOR 1.31 (95% CI 1.06-1.62) vs CM; AOR 1.27 (95% CI 1.04-1.56) vs controls without melanoma).
“AOE was significantly associated with higher odds of AM vs CM (AOR, 1.31; 95% CI, 1.06-1.62)”
HumansUS veterans; compared with nonacral cutaneous melanoma controls
Identification of Risk Factors for Acral Melanoma in US Veterans
JAMA dermatologyFeb 4, 2026